Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 41 (RPL12P41)

Target
RPL12P41
Molecular classification
Other (processed pseudogene; does not fit conventional protein family classifications like receptor, enzyme, etc.)
01

Overview

Ribosomal protein L12 pseudogene 41 (RPL12P41) is a processed pseudogene based on the sequence of the ribosomal protein L12 gene. Pseudogenes are genetic elements derived from protein-coding genes that usually lack the ability to encode functional proteins due to disruptive mutations, deletions, or insertions. RPL12P41 does not contribute to ribosomal function or protein synthesis, nor has it been characterized as a therapeutic target. Its classification is distinct from the functional ribosomal protein L12, which is a component of the 60S ribosomal subunit and is involved in translation in eukaryotic cells[1][4][6]. Pseudogenes like RPL12P41 may occasionally play a role in regulating gene expression of their parent gene but are not known to have a direct role in human disease or as therapeutic targets.

Other names
RPL12P41ribosomal protein L12 pseudogene 41RPL12_21_1660Human RPL12P41 (100133139)
02

Mechanism of action

None (there are no mechanisms of action because this entity is not a functional protein target for drugs)

03

Biological functions

Other (pseudogenes typically do not exert a direct biological function; functional role, if any, is usually via regulation of their parent gene or by acting as competing endogenous RNAs)
04

Disease associations

Other (pseudogenes themselves are rarely implicated directly in disease; parent gene RPL12 is associated with Diamond-Blackfan anemia[1], but not specifically the pseudogene)
05

Safety considerations

None applicable (not a functional target, so no direct safety concerns or therapeutic challenges associated)
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 41 (RPL12P41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 41 (RPL12P41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call